Recombinant Human PDCD11 Protein (Yeast)，His

PDCD11, or Programmed Cell Death 11, is a protein that has gained attention in the fields of immunology and cancer research due to its role in regulating apoptotic pathways and immune responses. Initially identified as a factor influenced by tumor necrosis factor (TNF), PDCD11 is implicated in various cellular processes, including transcription regulation and the modulation of apoptosis in response to stress signals. Recent studies have highlighted its potential involvement in tumor progression, as altered expressions of PDCD11 have been observed in various cancers, including breast and lung cancer. The understanding of PDCD11's function is further expanded by its relationships with other key proteins in apoptotic signaling pathways, suggesting a complex interplay that could influence both normal cellular homeostasis and disease states. The recombinant production of PDCD11 allows researchers to study its structural and functional properties in detail, facilitating the elucidation of its mechanisms in cell death regulation and its potential as a therapeutic target. Moreover, the investigation of PDCD11 interactions with other biomolecules could unveil new insights into cancer therapies and immune modulation strategies. Thus, the research surrounding recombinant PDCD11 not only contributes to our understanding of apoptosis but also holds promise for developing innovative approaches to cancer treatment and enhancing immune responses against tumors.